Bladder cancer is in an advanced stage by the time it is detected in approximately a quarter of patients at presentation. The initial symptoms of this disease (e.g. blood in the urine) often go unnoticed or are mistaken for other conditions such as a bladder infection. As with any [...]
Malignant melanoma is the deadliest form of skin cancer. Fast-growing, melanoma is best beaten with an early and accurate diagnosis followed by the right treatment tailored to the patient based on the identification of a specific biomarker. Biomarkers can predict therapeutic response to treatment. [...]
The Precision Medicine Connective is on a quest to help improve the diagnostic testing part of the patient journey. An important way to do this is by empowering patients to ask to be tested in ways that are relevant to them. There are many problems that need addressing to [...]
The FDA intends to make the development and review of cancer drugs more efficient under the Real Time Oncology Review (RTOR) pilot program. Under this supplemental applications pilot, launched last year, evaluation of clinical data begins as soon as clinical data becomes available and results are [...]
The term “liquid biopsy” is defined by the College of American Pathologists (CAP) as assays that analyze proteins, DNA, or cancer cells that circulate in the blood. There is growing interest in the less invasive, less complicated liquid biopsy as an alternative option to traditional biopsies in [...]
The FMS-like tyrosine kinase 3 gene (FLT3) marker is present in 25-30% of all AML patients and indicates a poorer prognosis. The testing landscape is evolving and FLT3 diagnostic testing is now used in efficacy-based patient stratification, safety-based patient stratification and ongoing [...]
At Diaceutics we are using a number of tools to leverage our data and to generate actionable insights. We mine data to forecast market trends and to understand the changing biomarker landscape. We are able to understand the use of new biomarker targets over time, review the dissemination of [...]
Precision medicine is more impactful when we build a story through use of a complete and meaningful dataset. Many publications discuss the idea that precision medicine relies on smart technology and this is true. At Diaceutics we believe that smart technology needs to be paired with the right [...]